Ultrasound compared with angiography for leg artery blockages in chronic limb threatening ischemia
Checks how well ultrasound finds leg artery damage compared with angiography.
Key facts
- Who runs it
- Sohag University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Duplex Ultrasound Versus Conventional Angiography in Evaluating Lower Limb Threatening Ischemia
- Status
- Not yet recruiting
- People taking part
- 50 people, planned
- Started
- 2 Sept 2025
- Planned end
- 2 Apr 2026
- Type of study
- Interventional
- Treatments tested
- conventional angiography
- Record updated
- 8 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with chronic threatening lower limb ischemia, meaning poor blood flow to the leg. It compares Duplex Ultrasound with angiography, an X-ray scan of the arteries.
- Age
- 40 Years and older
- Sex
- All sexes
- Disease stage
- Chronic threatening lower limb ischemia, with pain at rest, a wound that does not heal, or gangrene.
Main reasons for not taking part
- Unstable blood pressure or circulation, so the person is not fit for angiography
- Artery disease not caused by hardening of the arteries, such as vasculitis or Buerger's disease
- Known allergy to contrast dye, or kidney problems that rule out contrast angiography
- A full Duplex Ultrasound exam is not possible, for example the ultrasound cannot see the arteries clearly
- Not able to give informed consent
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- 1. Clinical diagnosis of chronic threatening lower limb ischemia (rest pain, non-healing ulcer, or gangrene)
- Ability to provide informed consent
Who cannot take part
- 1. Hemodynamically unstable patients not fit for angiography. 2. Patients with non-atherosclerotic arterial diseases (e.g., vasculitis, Buerger's disease); Known contrast allergy or renal insufficiency precluding contrast angiography; Inadequate acoustic window or inability to undergo complete DUS examination
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to evaluate the accuracy of Duplex Ultrasound (DUS) in assessing infra inguinal arterial lesions in patients with chronic threatening limb ischemia compared with digital subtraction angiography (DSA) as the reference standard. By comparing sensitivity, specificity, and predictive values across arterial segments, the study seeks to determine the clinical utility of DUS as a non-invasive alternative for pre-intervention vascular mapping in chronic limb-threatening ischemia.
The group in the trial
- patients with chronic threatening limb ischemiaTreatment being tested
Duplex Ultrasound (DUS) assessment of infra inguinal arterial lesions in patients with chronic threatening limb ischemia and then compared with digital subtraction angiography (DSA) as the reference standard.
Treatment: conventional angiography
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Diagnostic Value of Duplex Ultrasound in Evaluating Infra Inguinal Arteries in Patients With Chronic Limb Threatening Ischemia : A Comparative Study With Angiography
- Plain-language title
- Ultrasound compared with angiography for leg artery blockages in chronic limb threatening ischemiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 8 August 2025